Illness	Number of cases
Systemic sclerosis - Progressive systemic sclerosis (M34.0)	206
Other systemic involvement of connective tissue - Other specified systemic involvement of connective tissue (M35.8)	91
Other systemic involvement of connective tissue - Other overlap syndromes (M35.1)	61
Other necrotizing vasculopathies (M31.3)	59
Systemic lupus erythematosus (M32.1)	43
Other peripheral vascular diseases - Thromboangiitis obliterans Buergers disease (I73.1)	26
Systemic sclerosis (M34.8)	26
Other necrotizing vasculopathies - Other giant cell arteritis (M31.6)	24
Other necrotizing vasculopathies - Microscopic polyangiitis (M31.7)	21
Other necrotizing vasculopathies - Other specified necrotizing vasculopathies (M31.8)	21

Top 10 treatments

Treatment	Number
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	217
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	195
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	176
Function-orientated physical exercises and uses (8-561.1)	118
(9-984.b)	115
(9-984.7)	90
Others therapeutic procedures to influence the immune system (8-547.31)	76
(9-984.8)	64
Others therapeutic procedures to influence the immune system (8-547.30)	53
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	50

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0900

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
61	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
45	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
33	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Doctoral supervision